Valuation: Illumina, Inc.

Market Cap 29.92B 25.98B 24.22B 22.25B 42.09B 2,846B 42.55B 286B 112B 1,423B 112B 110B 4,714B P/E 2026 *
40.7x
P/E 2027 * 34.1x
Enterprise Value 30.17B 26.2B 24.42B 22.44B 42.43B 2,870B 42.9B 288B 113B 1,435B 113B 111B 4,753B EV / Sales 2026 *
6.53x
EV / Sales 2027 * 5.96x
Free-Float
75.5%
Yield 2026 *
-
Yield 2027 * -
1 day+1.84%
1 week+4.58%
Current month-1.60%
1 month+3.85%
3 months+44.81%
6 months+50.39%
Current year+53.87%
1 week 189.47
Extreme 189.4705
207
1 month 178.88
Extreme 178.88
207
Current year 112.65
Extreme 112.65
207
1 year 88
Extreme 88
207
3 years 68.7
Extreme 68.7
207
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer 55 29/05/2025
Director TitleAgeSince
Director/Board Member 65 28/07/2016
Director/Board Member 66 01/01/2017
Director/Board Member 65 05/02/2019
Date Insider Type Main position Quantity % Market Cap.
30/06/26 Free

Director

167 0.0001%
30/06/26 Free

Director

142 0.0001%
30/06/26
Corvex Management LP
OtherCompany 0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+1.95%+4.58%+105.01%+7.54% 29.92B
-1.90%-1.93%+21.16%+3.03% 212B
-1.64%-1.84%-1.05%-23.30% 139B
-1.91%+1.63%-23.93%+18.88% 133B
+1.25%+6.34%-54.13%-3.43% 70.19B
+1.11%+6.85%+11.64%+12.40% 51.14B
-0.28%+8.57%-15.66%-20.88% 50.09B
-0.72%-1.01%+21.14%+10.15% 39.48B
+5.16%+3.19%+38.71%+36.66% 36.79B
+0.72%+9.39%-0.72%-7.60% 31.5B
Average +0.39%+4.99%+10.22%+3.34% 79.28B
Weighted average by Cap. -0.59%+3.97%+3.23%+1.26%

Financials

2026 *2027 *
Net sales 4.62B 4.01B 3.74B 3.43B 6.5B 439B 6.57B 44.08B 17.23B 220B 17.34B 16.96B 728B 4.9B 4.25B 3.97B 3.64B 6.89B 466B 6.96B 46.75B 18.28B 233B 18.39B 17.99B 772B
Net income 748M 649M 605M 556M 1.05B 71.13B 1.06B 7.14B 2.79B 35.56B 2.81B 2.75B 118B 886M 769M 717M 659M 1.25B 84.24B 1.26B 8.45B 3.3B 42.11B 3.33B 3.25B 140B
Net Debt 246M 214M 199M 183M 346M 23.4B 350M 2.35B 918M 11.7B 924M 904M 38.76B -729M -633M -590M -542M -1.03B -69.34B -1.04B -6.96B -2.72B -34.66B -2.74B -2.68B -115B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
04/08/26 $201.64 +1.76% 2,008,924
03/08/26 $198.16 -3.38% 2,612,022
31/07/26 $205.10 +0.00% 4,099,921
30/07/26 $205.09 +5.27% 2,770,354
29/07/26 $194.82 +0.95% 1,694,087
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
198.16USD
Average target price
195.16USD
Spread / Average Target
-1.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock